U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515261) titled 'pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study' on March 31.
Brief Summary: This study will evaluate the feasibility and preliminary efficacy of pBFS-guided TMS treatment at DMPFC in autism spectrum disorder comorbid with language delay.
Study Start Date: March 10, 2023
Study Type: INTERVENTIONAL
Condition:
Autism Spectrum Disorder With Language Delay
Intervention:
DEVICE: active iTBS
Each participant will receive 1800 pulse active iTBS (100% RMT) in each session, 3 sessions per day, 5 days per week for 8 weeks.
Recruitment Status: COMPLETED
Sponsor: Changping Laboratory
Published by HT Digital Conte...